Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates
- 28 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 97 (1) , 10-18
- https://doi.org/10.1111/j.1365-2249.1994.tb06572.x
Abstract
Ribosomal inactivating proteins such as gelonin (Gel) and ricin A chain (RTA) conjugated to MoAbs bind to specific target cells, and upon internalization inhibit protein synthesis, ultimately resulting in cell death. We report here that Gel anti-T cell MoAb conjugates are more cytotoxic than RTA conjugates when tested against human peripheral blood mononuclear cells (PBMC). This increased cytotoxicity is observed whether Gel is conjugated to the anti-T cell MoAb or to an anti-mouse immunoglobulin Fab' fragment which then binds to the murine anti-human T cell MoAb. Gel conjugates are not only effective at lower concentrations, but also produce a greater extent of inhibition of cellular proliferation. Moreover, a 10 min exposure to a Gel conjugate is as effective as a 90 h exposure to an RTA conjugate. When part of anti-T cell F(ab')2 or Fab' conjugates, Gel affects the early steps in cellular intoxication more than RTA; Gel conjugates bind more avidly and accelerate the modulation of antigen. In contrast, when part of whole IgG conjugates, Gel does not affect the binding to or modulation of surface antigen compared with RTA, while it does increase conjugate cytotoxicity. These observations suggest that Gel may be delivered more efficiently into the cytosol than RTA. A divergent intracellular pathway for Gel is also supported by the inability of chemical potentiators, which strongly enhance RTA potency, to affect Gel potency. These properties of Gel might also be advantageous for immunoconjugates made with other MoAbs or receptor-binding molecules.Keywords
This publication has 59 references indexed in Scilit:
- Efficacy of anti-CD5 F(AB′)2 and FAB′ immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient miceInternational Journal of Immunopharmacology, 1993
- Toxin-Targeted Design for Anticancer Therapy. II: Preparation and Biological Comparison of Different Chemically Linked Gelonin-Antibody ConjugatesJournal of Pharmaceutical Sciences, 1993
- Cytotoxicity of chimeric (human-murine) monoclonal antibody BR96 IgG, F(ab')2, and Fab' conjugated to Pseudomonas exotoxinBioconjugate Chemistry, 1992
- Cytotoxicity against human peripheral blood mononuclear cells and T cell lines mediated by anti-T cell immunotoxins in the absence of added potentiatorClinical and Experimental Immunology, 1991
- In vivo cytotoxic efficacy of immunotoxins prepared from anti-CD5 antibody linked to ricin A-chainCancer Immunology, Immunotherapy, 1991
- Substituted 2-iminothiolanes: reagents for the preparation of disulfide cross-linked conjugates with increased stabilityBioconjugate Chemistry, 1990
- Immunotoxin construction with a ribosome-inactivating protein from barleyBioconjugate Chemistry, 1990
- Human T Lymphocyte Differentiation Antigens as Target for Immunotoxins or Complement‐Mediated CytotoxicityScandinavian Journal of Immunology, 1988
- In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin.Journal of Clinical Investigation, 1988
- Weakly basic amines inhibit the proteolytic conversion of proalbumin to serum albumin in cultured rat hepatocytesEuropean Journal of Biochemistry, 1985